Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

EXELIXIS, INC. Director's Dealing 2010

Dec 10, 2010

30561_dirs_2010-12-10_ff6071de-a405-45f0-9a76-fc2bf08703f7.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: EXELIXIS INC (EXEL)
CIK: 0000939767
Period of Report: 2010-12-09

Reporting Person: Schwab Gisela (EVP & Chief Medical Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2010-12-09 Common Stock S 4112 $6.50 Disposed 7322 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 3274.5476 Indirect

Footnotes

F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 26, 2010.

F2: Shares acquired pursuant to the Exelixis, Inc. 2000 Employee Stock Purchase Plan.

F3: Includes 7,322 shares of common stock acquired pursuant to the Exelixis, Inc. 2000 Employee Stock Purchase Plan.

F4: Represents 3,274 shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated December 9, 2010.